Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
01/05/2025
The Chief Financial Officer of Yum! Brands stated that due to one-time expenses, the profit growth in the second quarter is expected to slow down.
Latest
9 m ago
Truist Securities: Maintains a Hold rating on Snap (SNAP.US), adjusted from a Buy rating, with a target price adjusted from $14.00 to $11.00.
9 m ago
The US Treasury Department is considering improving the repurchase plan after the market experienced turmoil.
9 m ago
Jones Trading: Downgrade Regulus Therapeutics (RGLS.US) rating from buy to hold, target price adjusted from $8.00 to $7.00.
11 m ago
Truist Securities: Maintains a buy rating on Regeneron Pharmaceuticals (REGN.US), adjusting the target price from $975.00 to $940.00.
11 m ago
Canadian investment bank group: Downgraded Regulus Therapeutics (RGLS.US) rating from buy to hold, target price adjusted from $28.00 to $11.00.
See all latest